季节性流感疫苗在男性和女性中的免疫应答、效力、效果和安全性是否存在差异?——一项系统综述
该系统综述检索了1990年1月至2018年6月间PubMed、EMBASE、CINAHL、Web of Science和clinicaltrials.gov收录的观察性研究及III/IV期试验,纳入46项按性别分层分析季节性流感疫苗免疫原性、效力、效果和/或安全性的研究。由于数据异质性和研究质量低,无法进行Meta分析;关于性别对免疫原性和效果的影响无法得出明确结论,但女性报告免疫接种后不良事件(AEFI)的发生率更高。
要点
- 女性接种季节性流感疫苗后报告的不良事件发生率高于男性。
- 性别对季节性流感疫苗免疫原性和效果的影响无法得出明确结论。
- 数据异质性和研究质量低导致无法进行Meta分析。
核心结论
- 关于性别对季节性流感疫苗免疫原性和效果的影响无法得出明确结论,但女性报告的免疫接种后不良事件发生率更高。
- 数据异质性和研究质量低导致无法进行Meta分析。
- 需要强调在生物医学研究中恰当使用性(sex)和性别(gender)术语。
- 需要更高质量的证据以更好地理解对流感疫苗反应的性别差异。
研究设计与样本
- 系统综述,检索PubMed、EMBASE、CINAHL、Web of Science和clinicaltrials.gov从1990年1月至2018年6月发表的英文或法文观察性研究及III/IV期试验。
- 由两名评价者独立筛选文献,并使用Cochrane工具(RoB和ROBINS-I)对纳入研究进行数据提取和质量评估。
- 共检索到5745条引文,最终纳入46项研究。
主要发现
- 46项纳入研究中,18项评估免疫原性,1项估计效力,6项测量效果,25项评价安全性(4项研究同时报告了两个按性别分层的结局)。
- 女性报告的免疫接种后不良事件发生率高于男性。
- 关于性别对免疫原性和效果的影响无法得出明确结论。
- 数据异质性和研究质量低导致无法进行Meta分析。
关键数值与推荐
- 18项研究评估免疫原性。
- 1项研究估计效力。
- 6项研究测量效果。
- 25项研究评价安全性。
- 4项研究同时报告了两个按性别分层的结局。
临床怎么用
- 原文未据此给出推荐。
局限性
- 数据异质性和研究质量低导致无法进行Meta分析。
- 关于性别对免疫原性和效果的影响无法得出明确结论。
- 需要更高质量的证据以更好地理解对流感疫苗反应的性别差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Seasonal influenza is an important cause of morbidity and mortality, despite being vaccine-preventable. Sex factors (genes and hormones) seem to impact individuals' susceptibility to infectious diseases and their response to vaccination. However, most vaccine studies do not explicitly assess sex differences in vaccine response, but rather adjust for sex. METHODS: We conducted a systematic review to analyze immunogenicity, efficacy, effectiveness and/or safety of seasonal influenza vaccine data stratified by sex. We searched PubMed, EMBASE, CINAHL, Web of Science and clinicaltrials.gov for observational studies and phase III/IV trials from January 1990 to June 2018, published in English or French. Two reviewers independently screened all references, then proceeded to data extraction and quality assessment using the Cochrane tools (RoB and ROBINS-I) on included studies. RESULTS: Of the 5,745 citations retrieved, 46 studies were included in the SR. Overall, 18 studies assessed immunogenicity, 1 estimated efficacy, 6 measured effectiveness and 25 evaluated safety of seasonal influenza vaccine in females and males (four studies reported on two sex-stratified outcomes concomitantly). CONCLUSION: No clear conclusion could be drawn regarding the effect of sex on the immunogenicity and effectiveness of seasonal influenza vaccine, but higher rates of adverse events following immunization (AEFIs) were reported in females. The heterogeneity of data and studies' low quality prevented us from conducting a meta-analysis. There is a need to emphasize on the appropriate use of the terms sex and gender in biomedical research. Evidence of higher quality is needed to better understand sex differences in response to influenza vaccine.
引用
- Tadount F, Doyon-Plourde P, Rafferty E, et al. Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females? - A systematic review. Vaccine. 2019. PMID: 31711676. doi:10.1016/j.vaccine.2019.10.091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。